Preclinical evidence for the potential of a bivalent fHBP vaccine to prevent Neisseria meningitidis Serogroup C Disease.

Harris, Shannon L

Preclinical evidence for the potential of a bivalent fHBP vaccine to prevent Neisseria meningitidis Serogroup C Disease. [electronic resource] - Human vaccines - 68-74 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

1554-8619

10.4161/hv.7.0.14564 doi


Animals
Antibodies, Bacterial--blood
Antigens, Bacterial--analysis
Bacterial Proteins--analysis
Base Sequence
Blood Bactericidal Activity
Cluster Analysis
Complement System Proteins--immunology
DNA, Bacterial--chemistry
Female
Flow Cytometry
Genotype
Humans
Macaca fascicularis
Male
Membrane Proteins--analysis
Meningococcal Infections--microbiology
Meningococcal Vaccines--administration & dosage
Models, Molecular
Molecular Sequence Data
Neisseria meningitidis, Serogroup C--chemistry
Rabbits
Sequence Analysis, DNA